Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
16.66 +0.29 / +1.77%
As of 1:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.66 0.00 / 0.00%
Volume: 5.1K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues803.0K1.5M12.0M122.0M
Cost of Goods Sold29.7M--362.0K4.8M
Depreciation And Amortization879.0K871.0K742.0K928.0K
Operating ExpensesGross Income-29.8M--10.9M116.3M
General Expenses7.9M42.8M72.8M92.1M
Research And Development--23.5M17.2M19.6M
Total Operating Expenses38.6M43.6M73.9M97.8M
Non-Operating ExpensesOperating Income-37.8M-42.2M-61.9M24.2M
Extraordinary Credit0.
Extraordinary Charge0.000.00-22.9M-2.6M
Interest Expense On Debt1.9M3.6M7.8M5.0M
Other Expenses117.0K-660.0K101.0K39.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.5M-46.3M-92.3M19.9M
Income Taxes-16.2M0.000.000.00
Preferred Dividend-3.4M-1.1M0.000.00
Discontinued Operations2.2M0.000.000.00
Extraordinary Items74.9M0.000.000.00
Net Income-21.0M-46.3M-92.3M19.9M
Shares To Calculate EPSShares To Calculate EPS23.9M17.4M31.8M42.3M
Shares To Calculate EPS Diluted23.9M17.4M31.8M50.6M
Earnings Per ShareEPS$31.39-$2.72-$2.90$0.32
EPS Diluted-$1.02-$2.72-$2.90$0.32